CATECHOLAMINE (NOREPINEPHRINE, EPINEPHRINE, DOPAMINE AND DERIVATIVES) - ANVISA Registration 81086830091

Access comprehensive regulatory information for CATECHOLAMINE (NOREPINEPHRINE, EPINEPHRINE, DOPAMINE AND DERIVATIVES) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81086830091 and manufactured by LDN- LABOR DIAGNOSTIKA NORD GMBH & CO, KG. The registration is held by FASTTEST DISTRIBUIDORA DE PRODUTOS PARA LABORATÓRIOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including RECIPE, CHROMSYSTEMS INSTRUMENTS & CHEMICALS GMBH, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
81086830091
Registration Details
ANVISA Registration Number: 81086830091
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Device Details

Registration Details

81086830091

25351294464202401

20037992000139

Company Information

Germany
PT: ALEMANHA

Dates and Status

Jun 17, 2024

VIGENTE

09/18/2025 19:00:01